Interleukin-2 (IL-2) is a molecule that amps up immune cells to fight off infections. While it is effective, the problem with IL-2 is that it causes a lot of toxicity in patients.
The advance paves the way for building entirely novel, custom-designed antibodies, enzymes and other biologically active proteins.
The Institute for Protein Design at the University of Washington School of Medicine has been awarded $11.3 million from the Open Phi
The ability to build transmembrane proteins opens the way for custom-designing structures that span living cell membranes and perform new tasks.
Two decades ago, the notion of building custom proteins and correctly predicting their structure was a dream.
Computationally designed protein assemblies, which display functions associated with living things, may pose ways to transport therapeutic cargos into cells without using viruses as vehicles.
Gamers will pit their wits against a real-life villain: a food poisoning called aflatoxin that can cause liver cancer and stunting.
Scientists have created a way to generate thousands of different mini-protein binders as possible drug candidates.
When a protein folds correctly, it spurs a biological process in a cell -- one of many that enable the human body to live. Our bodies have about 100,000 distinct proteins, built from strings of amino acids, and each protein has a job to do.